A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IVIg / intravenous immunoglobulin therapy

[Related PubMed/MEDLINE]
Total Number of Papers: 56
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IVIg  (>> Co-occurring Abbreviation)
Long Form:   intravenous immunoglobulin therapy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies. aPL, dRVVT, IgG, LAC
2020 Pure Red Cell Aplasia and Antibody-Mediated Rejection: Double Trouble in 1 Kidney Transplant Recipient Solved by Intravenous Immunoglobulin Infusion: A Case Report. PRCA
2020 Tregitopes regulate the tolerogenic immune response and decrease the foetal death rate in abortion-prone mouse matings. ---
2019 Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme. ---
2019 Effect of intravenous immunoglobulin therapy on anti-NT5C1A antibody-positive inclusion body myositis after successful treatment of hepatitis C: A case report. HCV, IBM, NT5C1A
2019 [Guillain-Barre syndrome with refractory optic neuropathy]. GBS
2018 Intravenous Immunoglobulin Therapy Administered Early after Narcolepsy Type 1 Onset in Three Patients Evaluated by Clinical and Polysomnographic Follow-Up. ---
2018 Severe Chronic Inflammatory Demyelinating Polyneuropathy Ameliorated following High-dose (3 g/kg) Intravenous Immunoglobulin Therapy. CIDP
10  2018 [Improvement of human T-lymphotropic virus type 1 associated demyelinating neuropathy with corticosteroid therapy]. CIDP, HTLV-1
11  2017 A case of seropositive autoimmune autonomic ganglionopathy with diffuse esophageal spasm. AAG, DES, IVMP
12  2017 Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses. HCMV, IEAs
13  2017 Strain-dependent neutralization reveals antigenic variation of human parechovirus 3. HPeV3, mAb, NAbs
14  2017 [Thirty years of platelet immunology in fetal and neonatal alloimmune thrombocytopenia management, current situation]. FNAIT
15  2016 Guillan-Barre syndrome following scrub typus: two case reports. GBS
16  2015 High-dose intravenous immunoglobulin therapy for rapidly progressive interstitial pneumonitis accompanied by anti-melanoma differentiation-associated gene 5 antibody-positive amyopathic dermatomyositis. ADM, CT, IVCY, MDA5, RPIP
17  2015 Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barre syndrome. ---
18  2015 Plasma Exchange Therapy in Patients with Complex Regional Pain Syndrome. CRPS, PE, QST
19  2014 Tregitope: Immunomodulation powerhouse. ---
20  2013 Current medical treatment of ocular mucous membrane pemphigoid. MMF, MMP, MTX
21  2013 Efficacy of high-dose intravenous immunoglobulin therapy for peripheral neuropathy in the remission stage of eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome). EGPA, MMT, VAS
22  2013 Optimization of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy evaluated by grip strength measurement. CIDP
23  2013 [A patient with Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barre syndrome having a complication of SIADH]. FS, PCB, SIADH
24  2013 [An 8-year-old boy with anti-NMDA receptor encephalitis, successfully treated with cyclophosphamide]. mPSL, NMDAR
25  2013 [Prognostic factors in Guillain-Barre syndrome]. EGOS, EGRIS, GBS
26  2012 A comparison between intravenous and subcutmaneous immunogobulin. MMN, SCIG
27  2012 Comparison of American and European practices in the management of patients with primary immunodeficiencies. AAAAI, ESID, PIDs, SCIG
28  2012 The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response. ---
29  2011 [Anti-aquaporin-4 antibody autoimmune syndrome with disturbance of consciousness, respiratory failure, and ophthalmoplegia associated with extensive brain stem involvement with intractable hiccup and nausea as an initial manifestation. A case report]. ---
30  2011 [Autoimmune neuropathies: diagnosis, treatment, and recent topics]. CIDP, GBS, MFS, MMN, PE
31  2011 [Rapid improvement by rituximab treatment in a case of demyelinating polyneuropathy with anti-myelin-associated glycoprotein antibody]. MAG, SGPG
32  2009 Acute autonomic, sensory and motor neuropathy: successful treatment with IVIg. AASMN
33  2009 [Senile-onset recurrent myelitis with anti-aquaporin-4 antibody]. AQP4, MS, NMO, OCB
34  2008 [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis]. IVCY, LEMS, mPSL, PCD, SCLC
35  2007 [Case of herpes zoster associated Guillain-Barre syndrome with a relapse of eruptions after intravenous immunoglobulin therapy]. CSF, GBS, VZV
36  2006 [Chronic inflammatory demyelinating polyneuropathy followed by systemic lupus erythematosus and Sjogren syndrome: a case report]. CIDP, CSF, MRIs, SLE, SS
37  2006 [Intermittent intravenous immunoglobulin infusion prevented relapses in patients with remission-exacerbation type chronic inflammatory demyelinating polyradiculoneuropathy]. CIDP
38  2006 [Intravenous immunoglobulin therapy: ELISA measurement of antidesmogleins 1 and 3 in three patients with pemphigus vulgaris]. ---
39  2005 Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery. IgM
40  2005 Initial intravenous gamma-globulin treatment failure in Iranian children with Kawasaki disease. KD
41  2004 A case report of the efficacy of apheresis for refractory autoimmune thrombocytopenia in a patient with systemic lupus erythematosus associated hemolytic anemia. AITP, DFPP, PA IgG, SLE
42  2004 [An autopsy case of systemic vasculitis associated with hepatitis C virus-related mixed cryoglobulinemia presenting severe peripheral neuropathy]. HCV, RF
43  2004 [High-dose intravenous immunoglobulin in the treatment of sensory ataxic neuropathy with Sjogren's syndrome: a case report]. ---
44  2003 [A case of Crow-Fukase syndrome with extramedullary plasmacytoma: marked clinical deterioration following a biopsy to plasmacytoma]. CFS, VEGF
45  2001 Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses. IIF
46  2001 Multifocal motor neuropathy. MMN
47  2000 Recent advances of therapeutic apheresis in Guillain-Barre syndrome. AIDP, GBS, PE, SA
48  1998 Intravenous immunoglobulin preparation increases myoplasmic calcium concentration by activating the dihydropyridine-ryanodine receptor complex. ---
49  1995 Intravenous immunoglobulin infusion therapy in women with recurrent spontaneous abortions of immune etiologies. ---
50  1995 Soluble CD4 antigen reactivity in intravenous immunoglobulin preparations: is it specific? DDIA, HAMA, mIgG, sCD4
51  1994 Immune thrombocytopenia and Fc receptor-mediated phagocyte function. HDRBC, MPS
52  1994 Requirements for safety and quality of intravenous immunoglobulin G preparations. GMP
53  1993 Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. CIDP
54  1992 [Autoimmune polyendocrine syndrome. Treatment with intravenous immunoglobulins]. ---
55  1990 High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. CIDP
56  1990 Partial neutralization of a lupus anticoagulant by human immunoglobulin. LA